VAM Agreements Set to Be Regulated at Policy Level, with Institutional Competitiveness Returning to Value Discovery
The valuation adjustment mechanism (VAM), often called the "invisible constitution" of China's primary market, has finally been placed on the regulatory operating table. On June 5, a "Guiding Opinion" from the General Office of the State Council threw a moderately sized stone into the pond, but the ripples were enough to send a shiver through institutions accustomed to sprinting in the gray areas. The policy explicitly signaled its intent to target "VAMs" for the first time—the message could not
Analysis
The valuation adjustment mechanism (VAM), once hailed as the "invisible constitution" of China's primary market, has now been placed under the regulatory scalpel. On June 5, a "Guiding Opinion" issued by the General Office of the State Council tossed a moderately sized stone into the pond, yet the ripples it stirred were enough to send a shiver down the spines of institutions long accustomed to sprinting through gray areas. For the first time, the policy has explicitly signaled its intent to "operate on" VAMs—a clear message that the era in which entrepreneurs were suffocated by capital agreements and institutions built firewalls through contractual clauses is finally drawing to a close.
Look at the state of today’s VAM agreements—they have long strayed from their original purpose as a straightforward tool to "motivate entrepreneurs to achieve targets." Instead, they have mutated into a universal plaster for shifting risk. Investment firms shout about "investing in people, investing in the future" while stuffing performance targets, IPO deadlines, and even absurd clauses like "founder divorce clauses" into their contracts. It’s as if a deal isn’t "rigorous" unless the founder’s personal assets are exposed to unlimited liability, pushed to the very edge of the cliff. This trend has turned investment into the sale of financial products, reducing entrepreneurs to "VAM slaves" working solely for capital. A healthy primary market should not be built on extreme exploitation of entrepreneurs or crude carving up of risk.
Even more ironic is that the prevalence of this approach lays bare the hollowing out of capabilities among some investment firms. When skills like industry insight and value-added support are lacking, a bulletproof VAM becomes the easiest form of "risk control." Post-investment management? Unnecessary, since the VAM clauses have it covered. Value discovery? Too much trouble—better to gamble on short-term financial metrics. Over time, professional investment has devolved into "clause rent-seeking." Some firms’ core competitiveness has shockingly become the "legal team that writes the toughest VAM clauses." Isn’t that a tragedy for the industry?
Regulatory intervention now might seem like pouring cold water on the market, but in reality, it is redrawing the lines on a marathon course that has veered off track. The goal is not to eliminate VAMs—within reasonable bounds, they are indeed useful tools for balancing information asymmetry and clarifying rights and responsibilities—but to drag them from the "private domain of wild growth" into the "public domain with clear rules." This means that blatantly unfair "tyrant clauses" may be deemed invalid in future judicial practice, and liability will increasingly be judged based on commercial rationality rather than strict contractual wording. The scales of justice will tilt more toward protecting entities that genuinely create value, rather than capital that merely excels at drafting documents.
Once the shortcut of "relying on harsh clauses to hedge bets" is blocked, institutions will have no choice but to return to the real arena of competition. Future success will hinge on the depth of industry insight, the quality of post-investment value-added services, and the ability to truly identify and support entrepreneurs through market cycles. This will flush out the excess among "clause speculators," but for genuinely capable institutions and the long-term health of the market overall, this "bitter medicine" is administered at just the right time. Market evolution often begins by closing off shortcuts that rely on brute-force simplicity.
Disclaimer: The above content is generated by AI and is for reference only.